611 - 620 of 4301 Drugs
Ativan Injection (lorazepam injection)
Ativan (lorazepam) Injection is a benzodiazepine with antianxiety, sedative, and anticonvulsant effects used for the treatment of status epilepticus, as well as in adult patients for preanesthetic medication, producing sedation (sleepiness or drowsiness), relief of anxiety, and a decreased ability to recall events related to the day of surgery.
ATNAA (atropine and pralidoxime chloride injection)
ATNAA (atropine and pralidoxime chloride injection) is a combination of a cholinergic muscarinic antagonist and a cholinesterase reactivator used to treat poisoning by susceptible organophosphorus nerve agents having anticholinesterase activity in adults.
Qulipta (atogepant tablets)
Qulipta (atogepant) is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of episodic migraine in adults.
Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn for injection)
Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) is a combination of Zaire ebolavirus glycoprotein-directed human monoclonal antibodies used to treat infection caused by Zaire ebolavirus in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Zaire ebolavirus infection.
Strattera (atomoxetine hcl)
Strattera (atomoxetine) is a selective norepinephrine reuptake inhibitor prescribed for treating attention deficit hyperactivity disorder (ADHD). Strattera is available as a generic drug.
Atorvaliq (atorvastatin)
Atorvaliq (atorvastatin calcium) is an HMG-CoA reductase inhibitor (statin) indicated to reduce the risk of heart attack (myocardial infarction, or MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD; MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD; non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure (CHF), and angina in adults with clinically evident CHD; as an adjunct to diet to reduce low-density lipoprotein (LDL-C) in: adults with primary hyperlipidemia and in adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH); as an adjunct to other LDL-C lowering therapies to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia; and as an adjunct to diet for the treatment of adults with primary dysbetalipoproteinemia and/or hypertriglyceridemia.
Lipitor (atorvastatin calcium)
Lipitor (atorvastatin) is a statin used for the treatment of elevated total cholesterol, LDL, triglycerides, and to elevate HDL cholesterol.
Mepron (atovaquone)
Mepron (atovaquone) is an antiprotozoal agent indicated for the prevention of Pneumocystis carinii pneumonia in patients who are intolerant to trimethoprim-sulfamethoxazole (TMP-SMX) and is indicated for the acute oral treatment of mild-to-moderate PCP in patients who are intolerant to TMP-SMX.
Malarone (atovaquone and proguanil hcl)
Malarone (atovaquone and proguanil hcl) is a combination of two antimalarial medications used to treat or prevent malaria, a disease caused by parasites. Parasites that cause malaria typically enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. Malarone is available in generic form.
Tracrium (atracurium besylate)
Tracrium (atracurium besylate) is a muscle relaxant used as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. The brand name Tracrium is discontinued, but generic versions may be available.